J&J Vows To Fix Compliance, Quality Issues In Investor Deal

Law360, New York (July 11, 2012, 10:31 PM EDT) -- In a settlement that would lay to rest a slew of investor suits against Johnson & Johnson, the drug giant on Wednesday agreed to adopt rigorous internal controls to tighten oversight of its global subsidiaries and ultimately hold company directors responsible for their actions.

The proposed agreement, filed in New Jersey federal court, resolves three coordinated derivative lawsuits against J&J, according to the investors' brief in support of the settlement. The suits sought to hold the board of directors liable for a series of regulatory and...
To view the full article, register now.